{"name":"Mebias Discovery, Inc","slug":"mebias-discovery-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPWVRMMTNWTzJKdmtxUXdzNGxQclpxcmRiSFRtQVByVjB6NjBONDFWWXhQXzNRMlNfS1lTdFVINl9XOC1NUUI1dno4THZfeXVrX284Rm1fVk9CM1ZWaWlxb3JlTzd2Z3lHbmFpYnhzU1Vybm1sQXZfRC10UHpKNnZiTzdxZXZoRnViQzhDbGw3eU5GNFc0cURkMXFOckItQk9adnR5YjEzcmpsbF9VNjE5bElOT2owQQ?oc=5","date":"2017-10-19","type":"pipeline","source":"Fierce Biotech","summary":"Mebias' mu opioids best morphine, Trevena drug in preclinical studies - Fierce Biotech","headline":"Mebias' mu opioids best morphine, Trevena drug in preclinical studies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}